Research - Suresnes, Île-de-France, France
AlgoTx develops novel solutions for complex pain. Our lead program, ATX01, targets highly prevalent Chemotherapy-Induced Peripheral Neuropathy and the orphan disease erythromelalgia.
Outlook
Apache
WordPress.org
Google Font API
Mobile Friendly
Bootstrap Framework